Bringing the Oncology Community Together
Head & Neck
Janet Hampton Describes the Distress Thermometer
Janet Hampton, RN, BS
Monday, May 23, 2011
Janet Hampton, RN, BS, OCN® from the University of Michigan Health System Cancer Center Describes the Distress Thermometer
SEE ALL VIDEOS FROM: Janet Hampton, RN, BS
Advances in the Management of Hepatic and Pancreatic Malignancies
Perry Shen, MD, FACS, and Clancy Clark, MD, from Wake Forest Baptist Health Comprehensive Cancer Center, discuss advances in the management of hepatic and pancreatic malignancies.
(Molecular) Pathways, Pathways, and More Pathways
The oncology we all learned over the past three decades will soon be a thing of the past, making way for therapy decisions based on what molecular switches should be turned on and off, and of equal importance, in what sequence.
Imatinib Therapy Matures: GIST Research Sheds Light on Mutations, Drug Levels
Recently reported data demonstrate that the presence of a specific mutation in PDGFRA predicts for the lack of activity for the imatinib in patients with gastrointestinal stromal tumors.
Dr. Ford on Docetaxel in Esophagogastric Cancer
Dr. Abou-Alfa on Doxorubicin Plus Sorafenib in Liver Cancer
Dr. Yao on Octreotide in Elderly Patients with NET
Most Popular Right Now
Lack of Discontinuation of Statin Therapy After Diagnosis of End-Stage Cancer
Clinical Pathways: An Evolutionary Approach to Cancer Care
Study Suggests Role for Targeting HER2 in Non-Small Cell Lung Cancer
Supreme Court Limits Ability to Patent Genes in Landmark Decision
Optimal Radiation Delivery Methods and Dosing Strategies Under Study
Tweets by @OncLive
American Journal of Managed Care
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2013
Intellisphere, LLC. All Rights Reserved.